These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 30346702

  • 1. Welcome to the DARK Side: DARK Classics in Chemical Neuroscience.
    Lindsley CW.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2286. PubMed ID: 30346702
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The DARK Side of Total Synthesis: Strategies and Tactics in Psychoactive Drug Production.
    Chambers SA, DeSousa JM, Huseman ED, Townsend SD.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2307-2330. PubMed ID: 29342356
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA, Wurst MG, Daniels RN.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2438-2447. PubMed ID: 29956917
    [Abstract] [Full Text] [Related]

  • 6. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.
    Dunlap LE, Andrews AM, Olson DE.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2408-2427. PubMed ID: 30001118
    [Abstract] [Full Text] [Related]

  • 7. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D, Greenberg MI, Miller SN, Okaneku JT, Haggerty DA.
    Dis Mon; 2012 Feb 17; 58(2):38-89. PubMed ID: 22251899
    [No Abstract] [Full Text] [Related]

  • 8. DARK Classics in Chemical Neuroscience: Ibogaine.
    Wasko MJ, Witt-Enderby PA, Surratt CK.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2475-2483. PubMed ID: 30216039
    [Abstract] [Full Text] [Related]

  • 9. DARK Classics in Chemical Neuroscience: Methamphetamine.
    Abbruscato TJ, Trippier PC.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2373-2378. PubMed ID: 29602278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
    Glennon RA.
    J Med Chem; 2017 Apr 13; 60(7):2605-2628. PubMed ID: 28244748
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug-activation of brain reward pathways.
    Wise RA.
    Drug Alcohol Depend; 1998 Apr 13; 51(1-2):13-22. PubMed ID: 9716927
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Historical perspectives on the use of subjective effects measures in assessing the abuse potential of drugs.
    Jaffe JH, Jaffe FK.
    NIDA Res Monogr; 1989 Apr 13; 92():43-72. PubMed ID: 2512502
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.